Sign Up
OverviewAPI
The biopharmaceutical and biomedicine market is projected to reach a value of USD 1803.2 billion by 2034, driven by the increasing prevalence of chronic diseases and the demand for personalized medicine. Leading players in the market include Amgen Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., Merck Company Inc., and Pfizer Inc.

Ask a question